Skip to main content
. 2014 Oct 24;9(10):e111487. doi: 10.1371/journal.pone.0111487

Figure 7. COX-2 inhibitor treatment sensitizes BT20 and MCF7 spheroid and monolayer cells to TRAIL-mediated apoptosis.

Figure 7

MTT assay results quantifying the viability of BT20 and MCF7 cells under different treatment conditions (n = 5).